Dr. Jean-Patrice Baillargeon, MD, MSc, is Professor of Medicine at the Université de Sherbrooke, Canada, endocrinologist at the Centre hospitalier universitaire de Sherbrooke (CHUS) and clinical investigator at the Research Center of the CHUS. His primary areas of expertise include reproductive endocrinology, polycystic ovary syndrome, obesity, health system improvement and biostatistics/epidemiology. He completed a postdoctoral fellowship on the metabolic aspects of polycystic ovary syndrome (PCOS) under the supervision of Dr. Nestler in 2003 and obtained a Master’s in Clinical research and Biostatistics from the Virginia Commonwealth University, Richmond, USA. He is director of the Reproductive Endocrinology Clinic of the CHUS and director of the Clinical Investigator Resident Training Program of the Université de Sherbrooke.
Dr. Baillargeon has served has President-elect and then President of the Canadian Society of Endocrinology and Metabolism (CSEM), and he completed his term as Past-President of this Society in 2021. He is actually an active member of CSEM Nominating Committee, Planning Committee of the Annual Meeting, Awards Committee, and Continuous Professional Development Committee. He is also a Scientific Advisor of the main Quebec provincial funding agency (Fonds de recherche du Québec – Santé). Dr. Baillargeon is an internationally recognized expert in the metabolic aspects of the polycystic ovary syndrome and a Canadian expert in the management of obesity in preconception and fertility settings. He recently took over the leadership of an important transdisciplinary Sino-Canadian team that is conducting in Shanghai, China, a multi-centre randomized-controlled trial to test the impact of an evidence-based package of interventions on childhood overweight/obesity rates in 5-year-old children.